APAC offers stability in an increasing challenging global geopolitical environment for clinical stage drug development.

Since 2007, the contract laboratory Alphalyse A/S has developed and refined a new method of impurity analysis in biological ...

All physicians are faced with the challenge of how to help patients with no approved therapies for their diseases. What are ...

Day One Biopharma's OJEMDA FDA approval for pediatric glioma, but market concerns remain. Check out why I rate DAWN stock as ...

Understanding how tumors change their metabolism to resist treatments is a growing focus in cancer research. As cancer cells adapt to therapies, their metabolism often shifts, which can help them ...